Showing 1 - 2 results of 2 for search 'MV Jayanth', query time: 0.02s Refine Results
  1. 1
    Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India

    Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunog... by S Mangarule, S Palkar, M Mitra, MD Ravi, R Singh, A Moureau, MV Jayanth, DM Patel, S Ravinuthala, BN Patnaik, E Jordanov, F Noriega

    Published 2022-08-01
    Get full text
    Article
  2. 2
    Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6–8, 10–12, and 14–16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study

    Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6–8, 10–12, and 14–16 weeks of a... by S Mangarule, S Prashanth, A Kawade, MD Ravi, IV Padmavathi, S Palkar, VN Tripathi, R Singh, M Maurya, M Mitra, RS Shetty, RZ Kompithra, SM Dhaded, V Epari, A Moureau, MV Jayanth, K Varghese, S Ravinuthala, D Kukian, BN Patnaik, F Noriega

    Published 2022-12-01
    Get full text
    Article

Search Tools: